INP researchers and students massively attended NeuroFrance 2019

Image
neurofrance 2019

During the last NeuroFrance congress held from May 22 to 24, 2019 at the Palais des Congrès in Marseille, the INP distinguished itself through 20 posters, 4 oral communications, and 1 symposium moderation, not to mention the organization of the "Art in Mind" exhibition, showing not only the richness and quality of his research but also his open-mindedness. 

During the last NeuroFrance congress held from May 22 to 24, 2019 at the Palais des Congrès in Marseille, the INP distinguished itself through 20 posters, 4 oral communications, and 1 symposium moderation, not to mention the organization of the "Art in Mind" exhibition, showing not only the richness and quality of his research but also his open-mindedness. 

Chair :

  • François Féron,  co-chair of the symposium « Training the next generation of neuroscientists: scientific misconduct and publication ethics » and organizer of the « Art en tête » exhibit.

Symposia :

  • Maxime Bonnet, S21.5 - Functional recoveries after a cervical spinal cord injury and implantation of a thermosensitive hydrogel in rat
  • Anne-Marie François-Bellan, P2.126 - Effect of the long non-coding RNA Neat1 knock-down on the circadian transcriptome in a rat pituitary cell line
  • Bruno Gepner, S02.3 - EEG signature of the beneficial effects of slowness in autism. / Une signature EEG des effets bénéfiques de la lenteur dans l'autisme.
  • Christophe Leterrier, S11.5 - The axonal cytoskeleton: a nanoscale view / Le cytosquelette axonal à l´échelle nanoscopique.

Posters :

  • Laurie Arnaud, P1.055 - Human induced pluripotent stem cell-based Alzheimer's disease modeling reveals APOE4 as a modulator of inflammation
  • Kevin Baranger, P1.059 - The pro-amyloidogenic effects of membrane-type-matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking
  • Dominic Bingham, P1.003 - Organization and role of actin at the presynapse
  • Angélique Bole, P1.005 - Time course of α-actinin-2 expression within the dentate gyrus during epileptogenesis in the rat pilocarpine model of mesial temporal lobe epilepsy suggests its role in dendritic spines plasticity of hippocampal granule cells
  • Jean-Philippe Dales,  P1.042 - Gene expression profiling and pathway analysis in brain-derived microvascular endothelial cells treated with TWEAK and TNF cytokines
  • Patrick Decherchi, P1.116 - Delayed syngeneic transplantation of nasal olfactory stem cells improves locomotion and axogenesis after peroneal nerve injury
  • François Devred, P2.056 - Detecting brain diseases via plasma profiling
  • Eric Di Pasquale, P2.057 - Concomitant modification of synaptic activity by IL-1ß and metalloprotease MT5-MMP in primary cortical cultures
  • François Feron, P1.122 - Cholecalciferol (vitamin D3) reduces rat neuropathic pain by modulating opioid signaling
  • Laura García González, P2.072 - MT5-MMP affects the stability of β-CTF of amyloid precursor protein, which may constitute a new potential pathophysiological mechanism in Alzheimer´s disease
  • Gaelle Guiraudie-Capraz, P2.114 - The brain smells and tastes the self - lessons from the Allen Brain Atlas
  • Audrey Jacq, P2.126 - Effect of the long non-coding RNA Neat1 knock-down on the circadian transcriptome in a rat pituitary cell line
  • Michel Khrestchatisky,  P2.051 - Development of neurotensin analogues conjugated to a brain penetrant peptide that induce hypothermia and promote efficient neuroprotection in vivo and in vitro
  • Grigorios Kyriatzis, P2.052 - Expression and distribution of Neurotensin receptors in wild-type and epileptic conditions in relation to the neuroprotective effects of vectorized Neurotensin (VH-NT)
  • Anaïs Marie, P3.051 - Implication of vitamin A in neuroprotection of dopaminergic neurons in a rat model of Parkinson's disease
  • Alessandra Pagano, P2.049 - The Microtubule-associated protein Tau as a new putative therapeutic target in brain cancer
  • Dominika Pilat, P3.126 - MT5-MMP may influence early stages of Alzheimer´s disease through the control of neuroinflammation and amyloidogenesis
  • Kevin Sadelli, P3.082 - Therapeutic potential of autologous transplants of ecto-mesenchymal olfactory stem cells (EMs-OSCs) to repair hippocampal damage
  • Elodie Salebert, P3.148 - Executive functions and emotions in Alzheimer patients
  • Aurélie Soubéran, P3.042 - Inhibitor of apoptosis proteins determine glioblastoma stem-like cells fate in an oxygen-dependent manne
  • Jean Claude Stamegna, P3.089 - Syngeneic grafts of Olfactory Ecto-Mesenchymal Stem Cells restore breathing and locomotor functions in an acute rat model of high cervical contusion
  • Evgeni Zernii, P1.033 - Oxidative stress-induced disulfide dimerization of neuronal calcium sensor proteins

More information on the NeuroFrance 2019 congress website